Search research articles
Contact Us
Filters
Showing results (91-100 of 116) with videos related to
Page
of 12
Sort By:
Blood
|
October 9, 2014
BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein
Anupriya Agarwal, Ryan J Mackenzie, Arnaud Besson, et al.
Oncotarget
|
February 11, 2017
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
Paavo O Pietarinen, Christopher A Eide, Pilar Ayuda-Durán, et al.
Oncogene
|
March 13, 2021
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B
Alfonso E Bencomo-Alvarez, Andres J Rubio, Idaly M Olivas, et al.
Leukemia
|
June 19, 2019
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
Susan Branford, Dennis Dong Hwan Kim, Jane F Apperley, et al.
Cancer Research
|
April 12, 2013
Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis
Thomas O'Hare, Christopher A Eide, Anupriya Agarwal, et al.
Blood Cancer Discovery
|
September 12, 2023
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy
Christopher A Eide, Stephen E Kurtz, Andy Kaempf, et al.
Blood
|
February 7, 2008
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
Marc M Loriaux, Ross L Levine, Jeffrey W Tyner, et al.
The New England Journal of Medicine
|
May 10, 2013
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML
Julia E Maxson, Jason Gotlib, Daniel A Pollyea, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 9, 2017
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies
Stephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2024
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia
Rucha V Modak, Katia G de Oliveira Rebola, John McClatchy, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 116) with videos related to
Sort By:
Page
of 12
Blood
|
October 9, 2014
BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein
Anupriya Agarwal, Ryan J Mackenzie, Arnaud Besson, et al.
Oncotarget
|
February 11, 2017
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
Paavo O Pietarinen, Christopher A Eide, Pilar Ayuda-Durán, et al.
Oncogene
|
March 13, 2021
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B
Alfonso E Bencomo-Alvarez, Andres J Rubio, Idaly M Olivas, et al.
Leukemia
|
June 19, 2019
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
Susan Branford, Dennis Dong Hwan Kim, Jane F Apperley, et al.
Cancer Research
|
April 12, 2013
Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis
Thomas O'Hare, Christopher A Eide, Anupriya Agarwal, et al.
Blood Cancer Discovery
|
September 12, 2023
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy
Christopher A Eide, Stephen E Kurtz, Andy Kaempf, et al.
Blood
|
February 7, 2008
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
Marc M Loriaux, Ross L Levine, Jeffrey W Tyner, et al.
The New England Journal of Medicine
|
May 10, 2013
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML
Julia E Maxson, Jason Gotlib, Daniel A Pollyea, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 9, 2017
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies
Stephen E Kurtz, Christopher A Eide, Andy Kaempf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2024
Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia
Rucha V Modak, Katia G de Oliveira Rebola, John McClatchy, et al.
Page
of 12